31.10.16
XENIOS AG to be sold to Fresenius Medical Care

zfhn Zukunftsfonds Heilbronn brings industry giant in medical Technology to Heilbronn - another boost for the Technology site

>>
06.06.16
Development of a continuous variant of Greenovation´s biopharmaceutical production process

Press Release Greenovation

>>
05.04.16
XENiOS® AG Enrolls First Patient in “SynCor” Clinical Trial of its CE-Marked i-cor® Device to Treat Cardiogenic Shock
>>
22.02.16
„XENIOS invests in XOR-Labs Toronto“
>>
17.02.16
Successful collaboration with BioGenes
>>
10.12.15
Study demonstrates i-cor synchronized cardiac assist preserves left ventricular (LV) function compared to continuous-flow ECLS in cardiogenic shock
>>
01.12.15
Xenios Expands Manufacturing and R&D Operations
>>
23.11.15
Xenios AG receives CE mark for its i- cor Synchronized Cardiac Assist System
>>
06.11.15
The world’s first moss-produced drug candidate has the go-ahead to enter clinical trials.
>>
05.05.15
Greenovation filed phase I clinical trial application for its moss-aGal compound intended for treatment of patients suffering from Fabry Disease
>>
01.04.15
Greenovation and University of Freiburg cooperate to fight an Extremely Rare Disease
>>
12.03.15
GREENOVATION BIOTECH GMBH

Greenovation successfully completes preclinical toxicology studies of alpha – galactosidase

>>
15.10.14
Medimetrics Expands Medical Device Portfolio with New Fast Release IntelliCap Company Wins ISO and EN Certification for its Design & Development Capabilities
>>
07.10.14
SCHWARZER GmbH, Heilbronn Germany and CARDIOTEK B.V. Maastricht, The Netherlands announces that the two companies will merge under the new brand of Schwarzer Cardiotek
>>
30.07.13
Novalung GmbH and Medos Medizintechnik AG join forces to establish a common Holding Company
>>
16.05.13
PANATecs has formed a strategic alliance with HWI ANALYTIK GmbH

Since the start of this year, PANATecs GmbH has had a strategic alliance with HWI ANALYTIK GmbH, headquartered in Rülzheim.

>>
26.04.13
Compositence GmbH secures further growth through capital increase

Compositence GmbH, specializing in solutions for cost-effective serial production using carbon and glass fibers, has acquired an increase in capital.

>>
25.04.13
Novalung and Medos are bronze sponsors of the 2nd EURO-ELSO congress in Stockholm, Sweden

Like last year Novalung and Medos are one of the main sponsors of the 2nd Euro-ELSO Congress.

>>
16.04.13
Zieta Prozessdesign teamed up with Compositence

Zieta Prozessdesign teamed up with Compositence and brings together two innovative technologies FiDU and Composite Process to create the table: NOGI + CARBON TABLE TOP.

>>
11.04.13
Strategic alliance between PANATecs and Waters GmbH

Thanks to its latest strategic alliance with Waters GmbH, PANATecs can now offer Waters’ analytical standards and reagents

>>
11.04.13
Shanghai Funding Conference April, 18th 2013

Thomas R. Villinger presents Zukunftsfonds Heilbronn

>>
15.03.13
Novalung is Gold Sponsor of 33rd ISICEM in Brussels, Belgium, March 19-22, 2013

Winter is over - Spring starts with ISICEM

>>
07.03.13
greenovation Biotech offers BryokineTM FGF7 – first product for sale

Freiburg, March 6, 2013 - greenovation Biotech finished the expansion of their production capability in Freiburg and is now ready to produce large quantities of protein substances.

>>
28.02.13
Spring rebate on EdU cell proliferation kits

30% spring rebate on EdU cell proliferation kits Offer ends March 31, 2013!

>>
14.02.13
PANATecs GmbH in new facilities in Heilbronn

PANATecs is moving into modern, custom-built facilities in Heilbronn

>>
23.01.13
LiGalli, Dr. Willem de Laat and Medimetrics announce collaboration

Access to breakthrough technology set to bring personalised diagnosis and therapy into field of women’s health

>>